Stifel on Dianthus Therapeutics (NASDAQ: DNTH): 'today's update represents a best-case outcome, in our view'.The analyst comments "For the stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE